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In Escherichia coli, two main protein targeting path-
ways to the inner membrane exist: the SecB pathway for
the essentially posttranslational targeting of secretory
proteins and the SRP pathway for cotranslational tar-
geting of inner membrane proteins (IMPs). At the inner
membrane both pathways converge at the Sec translo-
case, which is capable of both linear transport into the
periplasm and lateral transport into the lipid bilayer.
The Sec-associated YidC appears to assist the lateral
transport of IMPs from the Sec translocase into the lipid
bilayer. It should be noted that targeting and transloca-
tion of only a handful of secretory proteins and IMPs
have been studied. These model proteins do not include
lipoproteins. Here, we have studied the targeting and
translocation of two secretory lipoproteins, the murein
lipoprotein and the bacteriocin release protein, using a
combined in vivo and in vitro approach. The data indi-
cate that both murein lipoprotein and bacteriocin re-
lease protein require the SRP pathway for efficient tar-
geting to the Sec translocase. Furthermore, we show
that YidC plays an important role in the targeting/trans-
location of both lipoproteins.
In the bacterium Escherichia coli, the SecB pathway targets
a subset of secretory proteins to the Sec translocase (1). The
chaperone SecB keeps secretory proteins in a translocation-
competent state. The SecB-preprotein complex is targeted at a
late stage during translation or after translation to the Sec
translocase in the inner membrane. The signal recognition
particle (SRP)1 pathway targets IMPs to the same or a very
similar Sec translocase in a cotranslational mechanism (2, 3).
The SRP, which consists of the Ffh protein and the 4.5 S RNA,
binds to the first transmembrane segment (TM) of an IMP
when it becomes exposed outside the ribosome. Upon contact of
the SRP with its receptor, FtsY, the nascent IMP dissociates
from the SRP and enters the Sec translocase.
The core of the Sec translocase consists of the IMPs, SecY
and SecE, and the peripheral subunit, SecA (1). SecY and SecE
form a protein-conducting channel (4), and SecA drives pro-
teins in an ATP-dependent process through this channel (1).
The Sec translocase catalyzes linear transport of secretory
proteins and of periplasmic domains of IMPs across the mem-
brane. In addition, TMs of IMPs are recognized in the Sec
translocase and laterally transferred into the lipid bilayer. The
Sec translocase-associated form of YidC appears to assist in
this lateral transfer of TMs (5, 6). YidC, which is present in
excess over the Sec translocase, is also involved in the integra-
tion of some small SRP/Sec-independent IMPs (7, 8). Thus far,
no evidence has been obtained that points to a role of YidC in
the targeting/translocation of secretory proteins across the in-
ner membrane (7, 9).2
It should be noted that in E. coli targeting and translocation
of only a handful of secretory proteins and IMPs have been
studied thoroughly. Hardly anything is known about the tar-
geting and translocation of lipoproteins, which in most cases
are secretory proteins. A lipoprotein is synthesized as a pre-
protein with an N-terminal signal sequence. Lipoproteins con-
tain a conserved sequence, the “lipobox,” that includes the
signal peptidase II (SPase II) cleavage site (10). The cysteine
located just after the SPaseII cleavage site is diacylglycerated
upon translocation; subsequently the signal sequence is clipped
off by SPaseII, yielding an apolipoprotein. Finally, the amino-
modified cysteine is fatty acylated, giving rise to the mature
lipoprotein (11). Secretory lipoproteins can, depending on the
sequence of the early mature region, remain associated to the
outer leaflet of the inner membrane or be transported by
the Lol system to the outer membrane (12).
To identify the components involved in the targeting and
translocation of secretory lipoproteins, we have analyzed the
maturation of two model secretory lipoproteins. Maturation of
lipoproteins has been studied in vivo using strains that are
mutated in targeting and translocation factors and in vitro
using a translation/cross-linking system. One of the two model
lipoproteins is the murein lipoprotein (Lpp), which is the most
abundant protein in E. coli. Lpp is attached to the inner leaflet
of the outer membrane of E. coli and forms stable trimers (13).
One of three Lpp molecules is covalently linked to the pepti-
doglycan layer (13). The other model lipoprotein is the
pCloCF13-encoded bacteriocin release protein (BRP) (14). The
BRP is essential for the translocation of the bacteriocin cloacin
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DF13, a bactericidal protein, across the cell envelope (14).
Notably, the BRP signal sequence is very stable after cleavage
from the preprotein, in contrast to other signal sequences, and
plays a yet undefined role in cloacin DF13 export (14).
Our combined in vivo and in vitro studies indicate that the
SRP pathway plays an important role in the targeting of Lpp
and BRP to the Sec translocase. Surprisingly, YidC is also
shown to function in the targeting/translocation of both secre-
tory lipoproteins.
MATERIALS AND METHODS
Reagents, Enzymes, and Sera—All restriction enzymes, T4 DNA
ligase, and alkaline phosphatase were purchased from Invitrogen. The
Expand long template PCR kit was from Roche Applied Science. The
QuikChange site-directed mutagenesis kit was from Stratagene, and
the Megashort script T7 transcription kit was from Ambion Inc.
[35S]methionine and protein A-Sepharose were from Amersham Bio-
sciences. Pansorbin was obtained from Merck. All other chemicals were
supplied by Sigma. Antiserum against hemagglutinin (HA) tag was
purchased from Sigma and AbCam. Antisera against L23 and L29 were
kind gifts from R. Brimacombe. The antisera against TF and SecA were
gifts from W. Wickner. Antisera against Ffh, YidC, and SecY were from
our own collection.
E. coli Strains, Plasmids, and Growth Conditions for in Vivo Target-
ing and Translocation Studies—E. coli strain TOP10F grown in Luria
Bertani medium was used for all plasmid constructions. In all lipopro-
tein expression vectors, the pCloDF13-encoded T1 terminator, which
regulates the expression of the pCloDF13-encoded BRP, was cloned
upstream of the genes encoding Lpp and BRP to prevent any back-
ground expression (15). Upon induction of expression, the T1 termina-
tor is “overruled.” The pCloDF13-encoded T1 terminator region was
amplified using pJL28 as a template (16). Primers were designed so
that both an NcoI site and a stop codon were introduced upstream and
an EcoRI site and a ribosome binding site were introduced downstream
of the T1 terminator region. The T1 terminator region was cloned
NcoI-EcoRI into pET21d, yielding pET21d-T1. Plasmids pET21d-T1Lpp
and pET21d-T1BRP were obtained by plasmid PCR and site-directed
mutagenesis using pGEM42-Lpp and pJL28, respectively, as templates
(17). A methionine codon was introduced at position 16 in the Lpp signal
sequence and position 17 in the BRP signal sequence (Fig. 1). In addi-
tion, a C-terminal 4  methionine tag was attached to both Lpp and
BRP to increase labeling efficiency. Subsequently, T1Lpp and T1BRP
were NcoI-HindIII-cloned into pEH1 (18), pEH3 (18), and pBAD24 (19),
yielding pEH1-T1Lpp, pEH3-T1Lpp, pBAD24-T1Lpp, pEH1-T1BRP,
pEH3-T1BRP, and pBAD24-T1BRP. Finally, the genetic information
coding for an HA tag with a stop codon at its 3 prime end (20), preceded
by a flexible linker (Pro-Gly-Gly) was fused to the 4 methionine-tagged
Lpp and BRP, using BamHI and HindIII sites. This yielded pEH1-
T1LppHA, pEH3-T1LppHA, pBAD24-T1LppHA, pEH1-T1BRPHA,
pEH3-T1BRPHA, and pBAD24-T1BRPHA. The nucleotide sequences of
all constructs were verified by DNA sequencing.
The Ffh conditional strain WAM121 was cultured in M9 minimal
medium supplemented with 0.2% arabinose as described previously
(21). To deplete cells for Ffh, cells were grown to mid-log phase in the
absence of arabinose. The 4.5 S RNA conditional strain FF283 was
cultured in M9 minimal medium supplemented with 1 mM IPTG as
described previously (21). To deplete cells for 4.5 S RNA, cells were
grown to mid-log phase in the absence of IPTG. The temperature-
sensitive amber suppressor SecA depletion strain BA13 and the control
strain DO251 were cultured in M9 minimal medium at 30 °C as de-
scribed previously (22, 23). To deplete cells for SecA, cells were grown to
mid-log phase at 41 °C. The SecE depletion strain CM124 was cultured
in M9 minimal medium supplemented with 0.2% glucose and 0.2%
L-arabinose as described previously (24, 25). To deplete cells for SecE,
cells were grown to mid-log phase in the absence of L-arabinose. The
temperature-sensitive amber suppressor YidC depletion strain
KO1672, along with its wild-type control strain KO1670 (26), were
cultured in M9 minimal medium at 30 °C overnight. To deplete KO1672
cells for YidC, cells were grown to mid-log phase at 42 °C. Where
appropriate, ampicillin (100 g ml1), chloramphenicol (30 g ml1),
kanamycin (50 g ml1), and tetracyclin (12.5 g ml1) were added to
the medium.
In Vivo Assay for Targeting and Translocation—The model lipopro-
teins Lpp and BRP were expressed by L-arabinose induction from the
pBAD24 vector in strains TOP10F, FF283, BA13, DO251, KO1672, and
KO1670 and by IPTG induction from the pEH1 vector in strain CM124
and the pEH3 vector in strain WAM121. For all experiments cells were
grown to mid-log phase. Expression of the constructs was induced for 3
min with either L-arabinose (0.2%) or IPTG (1 mM). When indicated, the
SPaseII inhibitor globomycin (final concentration 100 g ml1) was
added 5 min before induction. Cells were labeled with [35S]methionine
(60 Ci/ml, Ci  37 GBq) for 30 s before precipitation with trichloro-
acetic acid (final concentration 10%). Subsequently, the samples were
washed with acetone, resuspended in 10 mM Tris/2% SDS, and immu-
noprecipitated with anti-HA and anti-OmpA serum. Anti-HA immuno-
precipitations were analyzed by means of Tricine SDS-PAGE (16.5%
peptide criterion gels from Bio-Rad) and anti-OmpA immunoprecipita-
tions by means of standard SDS-PAGE. Gels were scanned by Fuji
FLA-3000 phosphorimaging using the Image Reader V1.8J/Image Gauge
V 3.45 software.
E. coli Strains, Plasmids, and Growth Conditions for in Vitro Stud-
ies—E. coli strain MC1061 grown in Luria Bertani medium supple-
mented with CaCl2 (10 mM) was used for all plasmid constructions. The
QuikChange site-directed mutagenesis kit was used for the construc-
tion of all point mutations. Strain MRE600 was used to prepare a lysate
for translation of in vitro synthesized mRNA and suppression of UAG
stop codons in the presence of (Tmd)Phe-tRNAsup. Inverted membrane
vesicles (IMVs) were prepared from strain MC4100 grown in Luria
Bertani medium.
Plasmid pC4Meth55LppTAG11 (Fig. 1) was constructed by plasmid
PCR and site-directed mutagenesis using pGEM42-Lpp as template
(17). Plasmid pC4Meth55BRPTAG10 was obtained by plasmid PCR
and site-directed mutagenesis using pJL28 as a template (16).
pC4Meth55LppTAG11 encodes truncated Lpp, and pC4Meth-
55BRPTAG10 encodes truncated BRP. A methionine has been intro-
duced at position 16 in the Lpp signal sequence and at position 17 in the
BRP signal sequence, and both Lpp and BRP have been fused to a
C-terminal 4  methionine tag to improve labeling efficiency. Plasmid
pC4Meth55LppTAG11 contains an amber mutation at position 11 in
the Lpp gene, and plasmid pC4Meth55BRPTAG10 contains an amber
mutation (TAG) at position 10 in the BRP gene to enable tRNAsup
photocross-linking (Fig. 1). Where appropriate, ampicillin (100 g ml1)
was added to the medium.
In Vitro Transcription, Translation, Targeting, and Cross-linking—
Truncated mRNA was prepared as described previously from HindIII-
linearized Lpp and BRP derivative plasmids. For photocross-linking,
(Tmd)Phe was site-specifically incorporated into nascent chains by sup-
pression of a UAG stop codon using (Tmd)Phe-tRNAsup in an E. coli in
vitro translation system containing [35S]methionine to label the nascent
chains. This procedure has been described previously (5, 27). Targeting
to IMVs, photocross-linking, and carbonate extraction (to separate sol-
uble and peripheral membrane proteins from integral membrane pro-
teins) was carried out as described previously (27). Carbonate-soluble
and -insoluble fractions were either trichloroacetic acid precipitated or
immunoprecipitated. The material used for immunoprecipitation was
2-fold the amount used for trichloroacetic acid precipitation. Release of
nascent chains from the ribosome was provoked by incubating the
nascent chains after translation for 10 min at 37 °C with EDTA (25
mM). Samples were analyzed using 15% Laemmli SDS-PAGE and phos-
phorimaging as described previously (27).
RESULTS
Model Lipoproteins—We have used the murein Lpp and the
pCloDF13-encoded BRP as model proteins to study the target-
ing and translocation of secretory lipoproteins in E. coli (13,
14). To improve the labeling of Lpp and BRP with [35S]methi-
onine, both lipoproteins were slightly modified. A methionine
was introduced in the signal sequences of both Lpp and BRP
(Fig. 1). This does not have a significant impact on the pre-
dicted hydrophobicity of the Lpp and BRP signal sequences,
and we felt confident that the introduction of a methionine
would affect Lpp and BRP signal sequence interactions only
marginally at the most. Actually, in the ColA and ColN BRPs,
which are homologous to the pCloDF13 BRP, a methionine
naturally occurs at this position. To further improve labeling, a
stretch of 4 methionines was attached to the very C terminus of
both Lpp and BRP. To be able to immunoprecipitate Lpp and
BRP in the in vivo experiments, the 9-amino acid-long influ-
enza virus HA epitope tag preceded by a flexible linker (Pro-
Gly-Gly) was attached to their C termini (Fig. 1) (20).
The modified pCloDF13-encoded BRP causes lysis upon over-
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expression, just like the wild-type version of the protein, and
the clipped off signal sequence is stable (results not shown). For
the sake of clarity, we refer in the rest of this report to the
modified lipoproteins as Lpp and BRP.
Translocation of Lpp and BRP across the Inner Membrane Is
Sec Translocase-dependent—To test whether the introduction
of the extra methionines and the HA tag interfere with the in
vivo processing and maturation of Lpp and BRP, the constructs
were studied in the E. coli TOP10F strain and Sec translocase
mutant strains. Maturation of lipoproteins occurs in three
steps: 1) the unmodified prolipoprotein (U-PLP) is converted
into a diacylated prolipoprotein (M-PLP) upon translocation
across the inner membrane, 2) cleavage of the signal sequence
by SPaseII yields the apolipoprotein, and 3) acylation of the
lipoprotein gives rise to the mature lipoprotein (11). Both Lpp
and BRP were expressed in the TOP10F strain in the absence
and presence of globomycin, which inhibits SPaseII. Inhibition
of SPaseII causes the accumulation of the M-PLP form of li-
poproteins (Fig. 2, lanes 1 and 2) (28). This was confirmed in
experiments where [3H]palmitate was used rather than
[35S]methionine to label cells in the presence of globomycin
(results not shown). Taken together, the modifications improve
labeling and facilitate immunoprecipitation of Lpp and BRP
without affecting their maturation.
Lpp and BRP were also expressed in SecE and SecA deple-
tion strains. Both SecE and SecA are key components of the Sec
translocase. Upon depletion of SecE, SecY is rapidly degraded
by the FtsH protease. Therefore, SecE depletion results in the
loss of the SecY/E core of the Sec translocase (29). SecA deple-
tion results in the loss of the motor of the Sec translocase (22).
Upon SecE and SecA depletion, the U-PLP form of both Lpp
and BRP accumulate (Fig. 2, lanes 3–6). This points to a key
role of the Sec translocase in the translocation of Lpp and BRP
across the inner membrane, corroborating previous studies
using Sec-conditional mutant strains (30–33).
Efficient in Vivo Targeting of Lpp and BRP Requires SRP—
How are Lpp and BRP targeted to the Sec translocase? The
SecB and the SRP pathways are the two main targeting path-
ways to the Sec translocase (34). In the absence of SecB, tar-
geting of both Lpp and BRP is not significantly affected (results
not shown).
We next investigated the role of the SRP in the targeting of
Lpp and BRP to the Sec translocase. The E. coli SRP consists of
the protein component Ffh and the RNA component 4.5 S RNA.
Both Ffh and 4.5 S RNA are essential for viability, and deple-
tion of either of the SRP components compromises the SRP
targeting pathway, thereby preventing the targeting of many
IMPs (3, 35, 36). Targeting of Lpp and BRP was studied both
under 4.5 S RNA and Ffh depletion conditions (Fig. 3, A and B).
Depletion of 4.5 S RNA (Fig. 3A) and of Ffh (Fig. 3B) both
resulted in accumulation of the unmodified precursor forms of
BRP (most pronounced) and Lpp (less pronounced). As a con-
trol, the processing of pro-OmpA, an outer membrane protein
that is targeted by SecB, was monitored in the same samples.
No effect of depletion of the SRP components could be detected,
confirming that the observed accumulation of U-PLP is not
because of more general secondary effects of SRP depletion.
Together, the results indicate that a functional SRP pathway is
required for efficient targeting of the BRP and, albeit to a lesser
extent, of the Lpp.
Efficient in Vivo Translocation of Lpp and BRP Requires
YidC—All IMPs studied so far require YidC for efficient assem-
bly into the inner membrane. It has been suggested that YidC
assists the transfer of TMs from the Sec translocase into the
lipid bilayer (5). So far, no evidence has been obtained pointing
to a role of YidC in the translocation of secretory proteins (6, 7,
27, 37, 38). However, the unexpected role of the SRP in the
targeting of BRP and Lpp prompted us to evaluate the role of
YidC in the translocation of these proteins using a tempera-
ture-sensitive strain that is conditional for YidC expression
(Fig. 4). To our surprise, depletion of YidC by growth at the
non-permissive temperature resulted in the accumulation of
unmodified precursor forms of BRP (most pronounced) and Lpp
(less pronounced). Again, the processing of pro-OmpA that is
translocated independent of YidC (7) was monitored as a con-
trol and appeared unaffected. The combined data suggest that
YidC plays a differential role in the translocation of both
lipoproteins.
FIG. 1. The model lipoproteins Lpp and BRP. The amino acid sequence of BRP, Lpp, and their derivatives used in this study: wild-type BRP
(WTBRP), in vitro construct 55BRPTAG10, in vivo construct BRP, wild-type Lpp (WTLPP), in vitro construct 54LPPTAG11, in vivo construct Lpp
(LPP). The SPaseII cleavage site is indicated by an arrow, the lipid modifiable cystein by C, inserted/added methionines by M, and attached
influenza virus hemagglutinin epitope tags with a black background. Between the methionine stretch and the HA tag there is a flexible linker
(PGG). Amber codons and stop codons are marked with an asterisk.
FIG. 2. Translocation of Lpp and BRP is affected by the SPa-
seII inhibitor globomycin and is Sec translocase-dependent.
TOP10F cells harboring either pBAD24-T1LppHA (top panel, lanes 1
and 2) or pBAD24-T1BRPHA (bottom panel, lanes 1 and 2) were cul-
tured in M9 medium and pulse-labeled in the absence and presence of
the SPaseII inhibitor, globomycin. CM124 (PAra-secE) cells harboring
either pEH1-T1LppHA (top panel, lanes 3 and 4) or pEH1-T1BRPHA
(bottom panel, lanes 3 and 4) were cultured in M9 medium with (SecE)
or without (SecE) L-arabinose. BA13 (SecA depletion strain, SecA)
cells and DO251 (control strain,SecA) cells harboring either pBAD24-
T1LppHA (top panel, lanes 5 and 6) or pBAD24-T1BRPHA (bottom
panel, lanes 5 and 6) were cultured in M9 medium at 41 °C (SecA
depletion conditions,SecA). Cells were pulse-labeled and processed as
described under ‘‘Materials and Methods.’’ Lpp and BRP were immu-
noprecipitated with anti-HA antiserum. The processing of Lpp and BRP
was not affected by Me2SO (DMSO) in which globomycin was dissolved.
The processing of the SpaseII-independent OmpA was not affected in
the presence of globomycin, and depletion of SecE and SecA was
checked by monitoring the accumulation of OmpA (results not shown).
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Nascent Lpp and BRP Synthesized in Vitro Cross-link to Ffh,
SecA, SecY, and YidC—To study the targeting and transloca-
tion of Lpp and BRP in more detail, we have used an in vitro
translation/photo cross-linking approach. In this assay, the
interactions of nascent (ribosome-associated) polypeptides with
cytosolic and membrane components are fixed and analyzed.
[35S]Methionine-radiolabeled nascent chains of Lpp and BRP
were synthesized in an E. coli cell-free extract from truncated
mRNA to a length of 55 amino acids. Assuming that the ribo-
some covers 35 amino acids, the Lpp and BRP signal se-
quences are expected to be exposed just outside the ribosome
(37). To specifically probe the molecular environment of the
signal sequence in the nascent Lpp and BRP species, a single
amber stop codon (TAG) was introduced in the center of the
hydrophobic core in the Lpp (position 11) and BRP (position 10)
signal sequences (Fig. 1). The amber stop codons were sup-
pressed during the in vitro translation by addition of (Tmd-
)Phe-tRNAsup, an amber suppressor tRNA that is amino-acy-
lated with the photo cross-linker (Tmd)Phe. In all constructs,
the TAGs were efficiently suppressed by (Tmd)Phe-tRNAsup
(data not shown). Purified inverted IMVs were added from the
start of the translation reaction to allow cotranslational mem-
brane targeting and interaction of the translation intermedi-
ates with the membrane. After the translation/insertion reac-
tion, one half of each sample was irradiated with UV light to
induce cross-linking; the other half was kept in the dark to
serve as a control. The samples were extracted with carbonate
to separate soluble and peripherally membrane-associated ma-
terial from membrane-integrated components. Cross-linking
partners were identified by immunoprecipitation. Without UV
irradiation, no cross-linking products were detected using both
Lpp and BRP nascent chains (data not shown). Upon transla-
tion but prior to UV irradiation, the samples were divided in
two, and EDTA was added to one aliquot to provoke the release
of the nascent chains from the ribosome. This allowed us to
assess the importance of the context of the ribosome for cross-
linking to the truncated Lpp and BRP species. EDTA has been
shown to disassemble ribosomes (37).
Both nascent Lpp and BRP were efficiently targeted to the
IMVs, judging from the relatively high (50%) carbonate re-
sistance. When the carbonate supernatant of UV-irradiated
samples was analyzed, Lpp nascent chains were shown to
cross-link Ffh, albeit inefficiently (Fig. 5A, lane 3), and the
chaperone trigger factor (TF, lane 4). The 30-kDa cross-link-
ing adducts represented cross-linking to a breakdown product
of Ffh, as observed before (39).
Cross-linking to both Ffh and TF appeared dependent on the
context of the ribosome (lanes 8, 9) consistent with earlier
studies (39, 40). In contrast, cross-linking to SecA was hardly
detectable unless the nascent chains were released from the
ribosomes prior to cross-linking (lanes 7, 10). Strong cross-
linking specific for the ribosome-associated Lpp was observed
to the ribosomal proteins L23 and L29 (lanes 5, 6). L23 and L29
are located near the exit site of the large ribosomal tunnel that
runs from the peptidyl transferase center to the surface of the
large ribosomal subunit (41). In the carbonate pellet, cross-
linking to SecY and (weakly) to YidC was observed that ap-
peared dependent on the ribosomal context (lanes 13, 14, 16,
17), again consistent with earlier studies (5, 37). In addition, in
the pellet fractions SecA cross-linking was detectable only upon
release of nascent Lpp from the ribosome. Together, the data
suggest that nascent Lpp leaves the ribosome via the major exit
tunnel near L23 and L29. Most likely, the signal sequence of a
small fraction of nascent Lpp contacts the SRP. However, the
majority of nascent Lpp is close to TF. Consistent with this
explanation, both the SRP and TF dock near L23/L29 on the
ribosome, probably in a mutually exclusive manner. Upon
forced release of the nascent chains from the ribosome, the
signal peptide loses contact with L23, L29, TF, and Ffh and is
free to bind SecA, part of which is carbonate-resistant. Nascent
Lpp is primarily targeted to SecY but also contacts YidC.
Qualitatively, very similar results were obtained when nas-
cent BRP was used instead of Lpp (Fig. 5B). However, cross-
linking to Ffh appeared much more prominent at the expense
of cross-linking to TF (lanes 1, 3, 7), especially when consider-
ing the small amount of SRP present in cells as compared with
TF (42, 43). Upon treatment with EDTA, cross-linking to Ffh
was no longer detectable (lane 8), but another unknown factor
FIG. 3. The SRP pathway is required for efficient targeting of
Lpp and BRP. A, FF283 (PIPTG-4.5 S RNA) cells were cultured in M9
medium with (4.5 S RNA) or without (4.5 S RNA) IPTG. Cells were
pulse-labeled and processed as described under ‘‘Materials and Meth-
ods.’’ Lpp and BRP were immunoprecipitated with anti-HA antiserum
and OmpA with OmpA antiserum. OmpA processing was not affected
upon 4.5 S RNA depletion. B, WAM121 (Para-ffh) cells harboring either
pEH3T1LppHA or pEH3T1BRPHA were cultured in M9 medium with
(Ffh) or without (Ffh) arabinose. Cells were pulse-labeled and pro-
cessed as described under ‘‘Materials and Methods.’’ Lpp and BRP were
immunoprecipitated with anti-HA antiserum and OmpA with OmpA
antiserum. OmpA processing was not affected upon Ffh depletion.
FIG. 4. YidC is required for efficient targeting of Lpp and BRP.
KO1670 (control strain, YidC) cells and KO1672 (YidC depletion
strain, YidC) cells were cultured in M9 medium at 42 °C (YidC de-
pletion conditions) and 30 °C (non-depletion conditions). Cells were
pulse-labeled and processed as described under ‘‘Materials and Meth-
ods.’’ Lpp and BRP were immunoprecipitated with anti-HA antiserum
and OmpA with OmpA antiserum. OmpA processing was not affected
upon YidC depletion. YidC depletion was monitored by means of West-
ern blotting and resulted, as expected, in a strong PspA response (Ref.
56 and results not shown).
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of about the same molecular mass (50 kDa) was cross-linked
(lane 2). Other notable differences were that ribosome-associ-
ated BRP also detectably cross-linked SecA (lane 1, 6), and
there was stronger cross-linking of targeted nascent BRP to
YidC (lane 11). Finally, a cross-linking adduct of 75 kDa was
observed in the carbonate pellet fractions both before and after
release of nascent BRP from the ribosome, which remains to be
identified (lanes 11, 12). The more prominent contacts with the
SRP and YidC suggest a more important role for these factors
in the targeting and translocation of BRP, corroborating the
in vivo data.
DISCUSSION
Here, we have studied in E. coli the targeting and translo-
cation of two secretory lipoproteins, Lpp and BRP, using a
combined in vivo and in vitro approach. Surprisingly, the signal
peptides of both nascent BRP and, to a lesser extent, Lpp show
cross-linking to the targeting factor SRP and to the Sec-asso-
ciated YidC, which are thought to function in the membrane
targeting and integration of integral IMPs. Consistent with
these in vitro results, BRP and, to a lesser extent, Lpp depend
on the presence of the SRP and YidC for efficient targeting to
and translocation across the inner membrane in vivo.
In vitro, Lpp and BRP nascent chains with a length of 55
amino acids, carrying a UV-inducible cross-linker in the middle
of the signal sequence, are also cross-linked to the ribosomal
components L23 and L29 and to the ribosome-associated chap-
erone TF. L23 and L29 are located near the exit of the pre-
sumed ribosomal tunnel (41) and have been cross-linked to
short nascent chains of other origin before (39, 44). L23 has
recently been shown to function as an attachment site for both
TF and SRP (39, 45, 46). Cross-link studies have identified TF
as the first chaperone to interact generically with nascent
polypeptides (47) unless they carry a particularly hydrophobic
targeting signal that has a high affinity for the SRP (39, 40, 48).
The mechanism that underlies the interplay between TF and
SRP at the nascent chain exit site and how this interplay
influences the mode of membrane targeting and insertion of a
particular nascent protein are still unresolved issues (39, 44).
FIG. 5. Interactions of nascent Lpp
and BRP. A, 55LppTAG11 was trans-
lated in the presence of IMVs and (Tmd)-
Phe-tRNAsup as described under ‘‘Materi-
als and Methods.’’ After translation, the
nascent chains were treated with EDTA
when indicated, UV irradiated, and sub-
sequently extracted with sodium carbon-
ate (Supernatant, lanes 1–10; Pellet,
lanes 11–18). UV-irradiated fractions
were immunoprecipitated using anti-
serum against Ffh, TF, L23, L29, SecA,
SecY, and YidC (lanes 3–10, 13–18). All
cross-linking adducts are indicated with
. B, in vitro translation, EDTA treat-
ment, cross-linking, and carbonate ex-
traction of nascent 55BRPTAG10 were
carried out as described under panel A.
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The SRP is primarily used for the targeting of IMPs that are
thought to benefit from a cotranslational insertion mechanism
to prevent aggregation of hydrophobic domains in the cyto-
plasm. Then why does the SRP appear to play such an impor-
tant role in the targeting of the secretory lipoprotein BRP?
First, the BRP signal sequence is very hydrophobic, more hy-
drophobic than many signal anchor sequences of SRP-depend-
ent IMPs and prone to aggregation if unprotected. Interaction
of the signal sequence with the SRP and cotranslational tar-
geting of BRP may be the best way to prevent uncontrolled
insertion of the hydrophobic BRP signal sequence into the
inner membrane and aggregation of BRP in the cytoplasm.
Recently, it has been suggested that basic amino acids in the N
region of a signal sequence contribute to SRP binding, probably
through the formation of salt bridges between the 4.5 S RNA
and positively charged amino acids in the N region (49). Strik-
ingly, the BRP signal sequence has 3 lysines in its N region,
which may enhance even more the affinity of the already very
hydrophobic BRP signal sequence for the SRP. These features
may compensate for the relatively short time window in which
the SRP can interact with nascent BRP, given that the BRP is
a very small protein. It should be noted that the BRP signal
peptide is peculiar in the sense that it is stable in the inner
membrane, whereas other cleaved signal peptides are rapidly
degraded upon cleavage from the precursor protein. Appar-
ently, the BRP signal peptide is recognized as a signal anchor
sequence of an IMP: it binds the SRP in the cytosol, inserts at
the Sec translocon, and is subsequently transferred to the lipid
bilayer as a stably folded unit assisted by YidC (see below).
The signal sequence of Lpp is not very hydrophobic, and its N
region contains only one positively charged amino acid. How-
ever, it does show (weak) SRP cross-linking and SRP depend-
ence in vivo. There are recent precedents of relatively non-
hydrophobic signal peptides that are yet able to funnel
passenger proteins into the SRP pathway (50). Therefore, it is
not unlikely that there are yet unknown features of a signal
sequence that can provoke SRP binding. There may be an
important biological reason for a preference of Lpp for the
SRP-targeting pathway. Lpp is the most abundant protein in E.
coli and, therefore, highly expressed. When the mature part of
Lpp is expressed in the cytoplasm it forms stable trimers (13).
It is conceivable that cotranslational targeting of Lpp via the
SRP pathway prevents the formation of Lpp trimers in the
cytoplasm, which would make it incompetent for translocation.
The partial effect of SRP depletion suggests that Lpp can also
travel via SecB. The lack of SecB did not significantly affect the
kinetics of Lpp translocation (32).3 However, pre-Lpp could be
detected in cytosolic aggregates isolated from a SecB null
strain.3 A similar flexibility in targeting has recently been
demonstrated for the autotransporter Hbp (9). Therefore, it is
not unlikely that when the capacity of the SRP pathway is
insufficient, the SecB pathway gets a more prominent role in
the targeting of Lpp and, perhaps, also BRP. Unfortunately, we
have not succeeded in studying the targeting of Lpp and BRP in
an Ffh depletion/SecB null mutant background. Therefore,
other modes of targeting, like spontaneous or mRNA targeting,
cannot be excluded at present (3, 51).
Cross-linking of Lpp and BRP nascent chains to SecA and
SecY and the almost completely blocked maturation of both
lipoproteins under SecA and SecE depletion conditions clearly
show that both Lpp and BRP are translocated by the Sec
translocase across the inner membrane, corroborating previous
in vivo studies (30–33, 52). Surprisingly, both BRP and, to
some extent, Lpp nascent chains are cross-linked to YidC, and
in vivo depletion of YidC affects the maturation of BRP and
Lpp. In the context of the Sec translocon, YidC is considered to
facilitate the transfer of TMs of IMPs from the Sec translocase
into the lipid bilayer without being essential for this process.
The role of YidC in the targeting/translocation of Lpp and BRP
is enigmatic. It is possible that YidC facilitates the lateral
movement of the Lpp and BRP signal sequences into the lipid
bilayer or that YidC chaperones Lpp and BRP to the SPaseII/
Lol system. It is also possible that there is a direct connection
between SRP dependence and YidC dependence. It has been
shown that the chloroplast homologues of SRP and YidC par-
ticipate in targeting complexes (53). Therefore, it cannot be
excluded that YidC plays a role in the SRP cycle, perhaps in the
reception of the SRP or FtsY. Interestingly, membranes iso-
lated from cells depleted of YidC show decreased levels of the
lipoprotein CyoA, which in contrast to Lpp and BRP is an
integral IMP (54, 55). This may point to a more general and not
yet understood role of YidC in the targeting/translocation of
lipoproteins. In conclusion, our results indicate that the SRP/
Sec/YidC pathway is used by the secretory lipoproteins Lpp
and BRP.
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